Nerve problems in Waldenström's macroglobulinemia
Part of Blood & lymphatic, Brain & nervous system, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This study looks at how common nerve problems (peripheral neuropathy) are in people with Waldenström's macroglobulinemia (WM), and how to best diagnose them. It aims to help doctors find nerve issues earlier and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Waldenström's macroglobulinemia (WM).
- You have symptoms of peripheral neuropathy, like numbness, tingling, weakness, or pain in your hands or feet.
- You have not already been tested for peripheral neuropathy and found to have no nerve issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at bone marrow stem cells in people with Waldenström macroglobulinemia (WM). It aims to understand how these cells work and may help improve future treatments for WM.
This study looks at “hyperviscosity,” meaning very thick blood, in people with Waldenström macroglobulinemia (WM). Your results may help doctors better understand who needs treatment and what tests should be used, even if thick blood is not found.
This study is a registry that collects information about adults with certain IgM-related blood conditions. It may help doctors better understand these illnesses and improve future care.
This study looks at a blood test called circulating tumor DNA, measured after 6 months of treatment, to see how well it predicts outcomes in people with Waldenström macroglobulinemia. It may help doctors better judge who is responding and who may need treatment adjustments earlier.
This trial tests a combination of three drugs (pirtobrutinib, venetoclax, and rituximab) for people newly diagnosed with Waldenstrom's macroglobulinemia who have not had treatment before and need therapy for their symptoms.
This study looks at medical records to understand what outcomes happen in people with Waldenström’s disease and how well certain factors predict those outcomes. It’s mainly about using past and planned follow-up data, which may help improve care for future patients.
Hear when a new Waldenstrom Macroglobulinaemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.